Alexandra Schuman | LifeSci Advisors, IR |
Dror Bashan | President & CEO |
Eyal Rubin | SVP & CFO |
John Vandermosten | Zacks Small Cap Research |
Good morning, ladies and gentlemen, and welcome to the Protalix First Quarter 2022 Financial and Business Results Conference Call. [Operator Instructions] I do reminder, this conference call is being recorded. I will now turn the conference over to our host, Alexandra Schuman of LifeSci Advisors, Investor Relations for Protalix.
You may begin your conference.
Thank you, operator and welcome to the Protalix BioTherapeutics’ first quarter 2022 financial results and business update conference call.